CHINA: LIFE-CYCLE INSIGHTS 

Chinese Flag.jpg

IPD’s Chinese subscription brings transparency to this large, complex, and highly opaque market, offering:

  • Easy-to-use Chinese brand, biosimilar,

       and generic drug launch 

       tracking schedules
 

  • Chinese litigation tracking and

       in-the-courtroom coverage with 

       real-time email updates

  • ƒPersonalized consults with local Chinese intellectual property analysts 
     

  • ƒWeekly updates including trending Chinese drug topics, recent publications,
    and loss-of-exclusivity information
     

  • Complete drug information with locally Chinese reviewed indications
     

  • Comprehensive Chinese clinical development tracking in every major disease class
     

  • Chinese API (DMF) information

Map_China.png